Lutz Bonacker is a seasoned executive with over 30 years of experience in the biotechnology and pharmaceutical industries. As the Chief Commercial Officer at Microbio, he leads the company's commercial strategy and its implementation. Microbio is an Australian biotech leader which is working to stop pathogens from destroying lives— and making a difference by providing clinicians with the tools they need to improve patient outcomes. Critically as well, Microbio is developing new tools to counter the existential threat of antimicrobial resistance.
Lutz has a proven track record of successfully launching and commercializing innovative therapies. He is passionate about bringing advanced therapies to patients in need and is dedicated to driving positive change in the healthcare industry.
Lutz is a dynamic speaker and thought leader in the field of advanced therapies. He is committed to sharing his expertise and insights with industry professionals to help shape the future of healthcare. Attendees at Advanced Therapies UK 2026 can expect to gain valuable knowledge and insights from Lutz's presentation on the future of advanced therapies.